MA45226A - Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate - Google Patents

Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate

Info

Publication number
MA45226A
MA45226A MA045226A MA45226A MA45226A MA 45226 A MA45226 A MA 45226A MA 045226 A MA045226 A MA 045226A MA 45226 A MA45226 A MA 45226A MA 45226 A MA45226 A MA 45226A
Authority
MA
Morocco
Prior art keywords
prevention
compositions
treatment
methods
related conditions
Prior art date
Application number
MA045226A
Other languages
English (en)
French (fr)
Inventor
Elisabeth Lindner
Orla Mccallion
Anna Sjögren
Maria Åkerman
Original Assignee
Oxthera Intellectual Property Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxthera Intellectual Property Ab filed Critical Oxthera Intellectual Property Ab
Publication of MA45226A publication Critical patent/MA45226A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA045226A 2016-06-13 2017-06-13 Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate MA45226A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1650828 2016-06-13

Publications (1)

Publication Number Publication Date
MA45226A true MA45226A (fr) 2019-04-17

Family

ID=59067657

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045226A MA45226A (fr) 2016-06-13 2017-06-13 Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate

Country Status (12)

Country Link
US (2) US10765709B2 (https=)
EP (1) EP3468572B1 (https=)
JP (1) JP7016353B2 (https=)
CN (1) CN109641019A (https=)
AU (1) AU2017286220A1 (https=)
CA (1) CA3023042A1 (https=)
ES (1) ES2913398T3 (https=)
IL (1) IL263477A (https=)
JO (1) JOP20180110A1 (https=)
MA (1) MA45226A (https=)
TN (1) TN2018000420A1 (https=)
WO (1) WO2017216165A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders
US20210386793A1 (en) * 2018-10-04 2021-12-16 Oxthera Intellectual Property Ab New medical use of oxalate-reducing bacteria
CN110607262B (zh) * 2019-09-25 2022-03-25 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
EP3839039A1 (en) * 2019-12-16 2021-06-23 4D Pharma Research Limited Providing bacterial biomass with improved storage stability
BR112022013867A2 (pt) * 2020-01-14 2022-09-13 Synlogic Operating Co Inc Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial
CA3175041A1 (en) * 2020-03-10 2021-09-16 Federation Bio Inc. Microbial consortia for the treatment of disease
EP4043018A1 (en) * 2021-02-10 2022-08-17 Charité - Universitätsmedizin Berlin Composition and method for reducing oxalate levels in patients receiving maintenance dialysis
CA3216136A1 (en) * 2021-04-30 2022-11-03 Aaron Blake Cowley Compositions for preserving anaerobic microorganisms and methods of making and using the same
WO2023102091A2 (en) * 2021-12-01 2023-06-08 Federation Bio, Inc. Microbial consortia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
BG61712B1 (bg) * 1994-12-29 1998-04-30 "Ел Би Булгарикум" ЕАД закваски за българско кисело мляко и млечнокисели продукти и методи за получаването им
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
JP4996780B2 (ja) 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
WO2005097176A2 (en) 2004-03-26 2005-10-20 University Of Florida Research Foundation, Inc. Modulating oxalate transport
CA2608862C (en) 2004-06-11 2020-05-05 Trustees Of Tufts College Silk-based drug delivery system
WO2007070052A2 (en) 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
JP5193626B2 (ja) 2008-02-20 2013-05-08 日本曹達株式会社 微生物農薬製剤の保存方法
US9714456B2 (en) 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders

Also Published As

Publication number Publication date
US20190125807A1 (en) 2019-05-02
AU2017286220A1 (en) 2018-12-06
TN2018000420A1 (en) 2020-06-15
EP3468572A1 (en) 2019-04-17
WO2017216165A1 (en) 2017-12-21
CN109641019A (zh) 2019-04-16
JOP20180110A1 (ar) 2019-01-30
ES2913398T3 (es) 2022-06-02
CA3023042A1 (en) 2017-12-21
US10765709B2 (en) 2020-09-08
US20210052670A1 (en) 2021-02-25
EP3468572B1 (en) 2022-03-02
IL263477A (en) 2019-01-31
JP2019521182A (ja) 2019-07-25
JP7016353B2 (ja) 2022-02-04

Similar Documents

Publication Publication Date Title
MA45226A (fr) Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate
EP3533466A4 (en) PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND / OR PREVENTION
EP3448398A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
EP3423100A4 (en) COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION AND METHOD FOR THE TREATMENT THEREOF
EP3541408A4 (en) COMPOSITIONS AND METHODS FOR TREATING ABERRATING ANGIOGENS
EP3432891A4 (en) METHOD FOR THE TREATMENT AND PREVENTION OF C. DIFFICILE
EP3374350A4 (en) HYDROXYPYRIDINONE- AND HYDROXYPYRIMIDINONE-BASED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP3390642A4 (en) COMPOSITIONS AND METHODS OF TREATING RETINITIS PIGMENTOSA 18 AND RETINITIS PIGMENTOSA 13
EP3405191A4 (en) METHOD AND COMPOSITIONS FOR TREATING HYPERHIDROSIS
EP3448421A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING SURGICAL ADHESIVES
EP3458079A4 (en) COMPOSITIONS AND METHODS FOR TREATING ACNE
EP3644983A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF FIBROTIC LUNG DISEASES
EP3500278A4 (en) METHOD AND COMPOSITIONS FOR TREATING DISEASES WITH RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS
EP3801478A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CALCIPHYLAXIA
EP3471722A4 (en) CONNECTIONS, COMPOSITIONS AND METHODS FOR PREVENTING AND / OR TREATING CANCER
EP3651801A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF MUSHROOM INFECTION
EP3368048A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSE
EP3632431A4 (en) AGENTS FOR PREVENTING OR TREATING BRAIN ATROPHY
MA41120A (fr) Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
EP3413904A4 (en) HERBAL COMPOSITIONS AND METHOD FOR PREVENTING AND TREATING PLANT OR NAIL INFECTIONS
EP2962693A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CANCER
EP3612184A4 (en) COMPOUNDS, COMPOSITIONS, AND PROCEDURES FOR TREATMENT OR PREVENTION OF ACUTE LUNG INJURY
EP3398614A4 (en) AGENTS FOR PREVENTION AND / OR TREATMENT OF MORBUS ALZHEIMER
EP3373922A4 (en) COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA
EP3294313A4 (en) METHODS RELATING TO THE PREVENTION AND TREATMENT OF DRUG RESISTANCE